1 November 1990 in Endocrine Reviews
I. Introduction THE mammary gland is a unique feature of mammals. Its chief biological function is to synthesizeand secrete milk, which is essential for the nourishment of mammalian young. The parenchymal portion of the mammary gland is derived embryologically from ectoderm, while the surrounding stroma comes from mesoderm. Mammary gland growth takes place during both fetal and postnatal life; the gland is the site of milk production and secretion, and in several species (including humans) it is also a site of occurrence of preneoplastic and neoplastic lesions. Thus the mammary gland is an important organ of study by biologists from various disciplines, including endocrinologists, tumor biologists, and developmental biologists. During the last 30 yr, the primary interest of our laboratory has been the understanding of the neoplastic transformation process in mammary epithelial cells. One fundamental characteristic of tumor cells vis à vis their normal counterparts is deregulation of growth. Since cell proliferation is a prerequisite for neoplastic transformation in target tissues, we have tried to understand the regulation of mammary epithelial cell growth. Toward this end we have utilized a variety of in vivo techniques, in vitro organ and explant culture systems, and also cell culture methodologies. These tools have aided in the analysis of the roles of hormones, growth factors, lipids, metabolic products, and even extracellular matrix components in the control of growth in mouse and rat mammary epithelial cells.
15 January 2022 in American Journal of Respiratory and Critical Care Medicine
Rationale: The current understanding of human lung development derives mostly from animal studies. Although transcript-level studies have analyzed human donor tissue to identify genes expressed during normal human lung development, protein-level analysis that would enable the generation of new hypotheses on the processes involved in pulmonary development are lacking. Objectives: To define the temporal dynamic of protein expression during human lung development. Methods: We performed proteomics analysis of human lungs at 10 distinct times from birth to 8 years to identify the molecular networks mediating postnatal lung maturation. Measurements and Main Results: We identified 8,938 proteins providing a comprehensive view of the developing human lung proteome. The analysis of the data supports the existence of distinct molecular substages of alveolar development and predicted the age of independent human lung samples, and extensive remodeling of the lung proteome occurred during postnatal development. Evidence of post-transcriptional control was identified in early postnatal development. An extensive extracellular matrix remodeling was supported by changes in the proteome during alveologenesis. The concept of maturation of the immune system as an inherent part of normal lung development was substantiated by flow cytometry and transcriptomics. Conclusions: This study provides the first in-depth characterization of the human lung proteome during development, providing a unique proteomic resource freely accessible at Lungmap.net. The data support the extensive remodeling of the lung proteome during development, the existence of molecular substages of alveologenesis, and evidence of post-transcriptional control in early postnatal development.
1 October 2023 in American Journal of Physiology-Lung Cellular and Molecular Physiology
We provide new insights into the natural history of bronchopulmonary dysplasia in donor human lungs after the neonatal intensive care unit hospitalization. This study provides new insights into how the proteome and histopathology of BPD changes in early childhood, uncovering novel pathways for future study.
15 April 2023 in Decision Making: Applications in Management and Engineering
Investment extortion in the stock market is a crucial aspect considered by the investors. Therefore, investors implemented different strategies. This study was intended at constructing an investment portfolio (IP) of stocks within the NSE 100 listed companies of Non-parametric nature, fulfilling the basic premise of portfolio making that is, reducing risks while yielding an attractive return higher than any other instrument for the investors. Using DP omnibus test, the desired sample of companies following the non-normal distribution was achieved. Using financial beta, we have selected the outcome based on the nature of their ‘return’ and ‘risk'. We introduce TOPSIS (Technique for order of performance by similarity to ideal solution), a multi-criteria decision-making process (MCDM) to study the profitability of stocks, rank wise for each year, and finally, the Bayes portfolio model help to select the overall profitability associate with low risk for the construction of the portfolio.
30 August 2019 in International Journal of Innovative Technology and Exploring Engineering
Portfolio formation holds paramount importance in the process of the investment decision making since, a single door investment (SDI) option is much riskier than a multiple door investment (MDI) option. Among available financial instruments, the stock market (SM) has allured investors because of its liquidity and growth opportunities. However, the effectiveness of the investment decision is largely reflected in the selection of the constituent elements of the portfolio by an investor while trading off risk and return. In this paper, after an initial level selection of for formulating a possible portfolio by using Perceptual Map (PM), we have applied DEA to calculate the efficiency of the stocks at the risk-return interface based on the market performance. In order to ascertain that the stock selection is logical and worthwhile, we further probe the fundamental performances over a time period of five consecutive financial years using the method of Multi-Criteria Decision Analysis (MCDA) framework based on the Complex Proportional Assessment (COPRAS) method, where, the criteria weights are calculated by using the entropy method. A consistency is visible in the yearly fundamental performances and a significant pattern with regard to the portfolio selection.